Italia

12 nuovi farmaci in commercio

Nuove specialitÓ medicinali:Caretopic, Leviosa, Monoferric, Riastap, Sunosi.5 nuovi farmaci equivalenti

Nuove specialità medicinali
CARETOPIC spray 18 ml 2,275 mg/ml finasteride
DIFA COOPER AIC:049013016 68,00€ Cnn/RR in commercio dal:23/04/2021

LEVIOSA collirio 5 ml 0,1% + 0,5% desametasone sodio fosfato/levofloxacina emiidrato
NTC AIC:047871013 19,00€ Cnn/RR in commercio dal:13/05/2021

MONOFERRIC 1 flaconcino 5 ml 100 mg/ml ferro (III) isomaltoside 1000
PHARMACOSMOS A/S AIC:045642143 231,00€ Cnn/OSP in commercio dal:03/05/2021

MONOFERRIC 1 flaconcino 10 ml 100 mg/ml ferro (III) isomaltoside 1000
PHARMACOSMOS A/S AIC:045642170 462,00€ Cnn/OSP in commercio dal:03/05/2021

RIASTAP flaconcino polv EV 1 g 20 mg/ml + 1 filtro + 1 dispositivo di trasferimento fibrinogeno umano liofilizzato
CSL BEHRING AIC:040170021 726,18€ Cnn/RR in commercio dal:21/04/2021

SUNOSI 28 cpr riv 75 mg solriamfetolo cloridrato
JAZZ PHARMACEUTICALS AIC:048446025 358,75€ A /RRL in commercio dal:19/04/2021

SUNOSI 28 cpr riv 150 mg solriamfetolo cloridrato
JAZZ PHARMACEUTICALS AIC:048446076 502,26€ A /RRL in commercio dal:19/04/2021

Nuovi farmaci equivalenti 
DASATINIB MYLAN 60 cpr riv 50 mg dasatinib
MYLAN AIC:047966015 3.985,10€ H /RNRL in commercio dal:21/04/2021

DASATINIB MYLAN 30 cpr riv 80 mg dasatinib
MYLAN AIC:047966078 3.985,10€ H /RNRL in commercio dal:21/04/2021

DASATINIB MYLAN 30 cpr riv 100 mg dasatinib
MYLAN AIC:047966104 3.985,10€ H /RNRL in commercio dal:21/04/2021

DASATINIB MYLAN 30 cpr riv 140 mg dasatinib
MYLAN AIC:047966130 3.985,10€ H /RNRL in commercio dal:21/04/2021

ERTAPENEM AUROBINDO 1 flaconcino EV 1 g ertapenem sodico
AUROBINDO AIC:045004013 46,92€ H /OSP in commercio dal:23/04/2021

SEZIONE DOWNLOAD